These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38029029)

  • 41. [Ano-genital lesions due to human papillomavirus infection in women].
    Heard I
    Med Mal Infect; 2005 May; 35(5):302-5. PubMed ID: 15876506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

  • 43. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of p16
    Pandey A; Chandra S; Nautiyal R; Shrivastav V
    South Asian J Cancer; 2018; 7(4):236-239. PubMed ID: 30430091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
    Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
    Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
    Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
    Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Precancerous lesions of the uterine cervix: morphology and molecular pathology].
    Horn LC; Klostermann K
    Pathologe; 2011 Nov; 32 Suppl 2():242-54. PubMed ID: 21909794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women.
    Lin ZH; Shen XH; Jin Z; Kim Y; Lee E; Kim H; Kim I
    Pathol Int; 2005 Aug; 55(8):491-6. PubMed ID: 15998377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of enzyme-linked immunosorbent assay plasma p16INK4a protein in squamous cell carcinoma in uterine cervix: A case-control study.
    Raju K; Raghuveer CV; Sheela SR; Natarajan A; Jagadish TV; Sunil BN; Sharat B
    J Cancer Res Ther; 2022; 18(1):152-157. PubMed ID: 35381777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histomorphological Spectrum of Cervical Lesions in a Rural Hospital.
    Vijayakumar S; Sinha P; Krishnamurthy D
    Cureus; 2021 Sep; 13(9):e18293. PubMed ID: 34722069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pregnancy related cervical cytological changes and clinical management].
    Ma L; Bian ML; Liu J; Wang XH; Pang CH; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):84-7. PubMed ID: 21426763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential diagnostic value of P16 expression in premalignant and malignant cervical lesions.
    Izadi-Mood N; Asadi K; Shojaei H; Sarmadi S; Ahmadi SA; Sani S; Chelavi LH
    J Res Med Sci; 2012 May; 17(5):428-33. PubMed ID: 23626605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of conventional and liquid-based Pap smear methods in the diagnosis of precancerous cervical lesions.
    Honarvar Z; Zarisfi Z; Salari Sedigh S; Masoumi Shahrbabak M
    J Obstet Gynaecol; 2022 Aug; 42(6):2320-2324. PubMed ID: 35579303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinicopathological analysis of cervical basaloid squamous cell carcinoma].
    Wang LQ; Wang Y; Jin W; Cao C; Ma YQ; Ding XH; Liu AJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jan; 54(1):7-12. PubMed ID: 30695899
    [No Abstract]   [Full Text] [Related]  

  • 56. Cervical cytopathological changes in pregnancy: An experience from a low resource setting.
    Rasheed FA; Yakasai IA; Takai IU; Yusuf I; Ibrahim UM
    Ann Afr Med; 2021; 20(3):212-221. PubMed ID: 34558451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-neoplastic diseases of the cervix in Nigerians: a histopathological study.
    Omoniyi-Esan OG; Osasan SA; Ojo OS
    Afr Health Sci; 2006 Jun; 6(2):76-80. PubMed ID: 16916295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
    Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
    Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visual inspection of cervix with Lugol's iodine for early detection of premalignant & malignant lesions of cervix.
    Ghosh P; Gandhi G; Kochhar PK; Zutshi V; Batra S
    Indian J Med Res; 2012 Aug; 136(2):265-71. PubMed ID: 22960894
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.